BCR and neoplasm: In line with that suggestion, while 34% (P = 0.0396) of patients in the Malmö TMA displaying high levels of TPβ in the tumour progressed to BCR, that figure increased to 41% (P = 0.0017) in patients showing both high TPα and TPβ expression in the tumour region, where in both instances the mean time to progression to BCR was 42–43 months post-surgery.